All lobbying filings

CAPITOL HILL CONSULTING GROUP

Lobbying for TEVA PHARMACEUTICALS USA · Generic and biosimilar manufacturer.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Apr 21, 2025

Official filing document

Lobbying activity 3

Trade (domestic/foreign)

Issues related to potential tariffs on generic drugs.

Health Issues

Issues surrounding US Pharmaceutical supply chain. Issues surrounding the generic drug and biosimilar user free agreements. Issues surrounding the regulation of complex generic drugs. Issues related to Inflation Reduction Act.

Medicare/Medicaid

Issues surrounding Medicare reimbursement of generic drugs and biosimilars. Issues relating to the impact of prescription drug negotiation on generic drugs. Issues related to drug shortages.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.